Although, in southern Europe, there has been considerable experience in the treatment of visceral leishmaniasis (VL) in HIV-positive patients, the optimal therapy has yet to be established. Pentavalent antimony salts, free amphotericin B deoxycholate (ABD) and lipidic formulations of amphotericin B are the drugs most commonly used. Treatment with pentavalent antimonials requires daily injection...

In recent years, several reports have emphasized the increasing importance of visceral leishmaniasis as an opportunistic infection among HIV-positive patients in areas where both infections are endemic. Major challenges in the treatment of leishmaniasis include widespread resistance to pentavalent antimonial compounds, absence of safe chemotherapeutic agents, and treatment failure and relapses ...

BACKGROUND Coordination compounds of pentavalent antimony have been, and remain, the first-line drugs in leishmaniasis treatment for >70 years. Molecular forms of Sb (V) complexes are commercialized as sodium stibogluconate (Pentostam®) and meglumine antimoniate (MA) (Glucantime®). Ever-increasing drug resistance in the parasites limits the use of antimonials, due to the low drug concentrations...

Visceral leishmaniasis (VL) affects over 500,000 people worldwide each year. The disease occurs in the Mediterranean basin, Central and South America and is caused by Leishmania infantum (syn L. chagasi). VL is an endemic disease in Colombia, particularly along the Caribbean coast and the Magdalena River Valley and 90% of VL cases occur in children under the age of five. The first line of treat...

As per World Health Organization, Leishmaniasis is a neglected, tropical disease. It initiated by intracellular transmission of parasite to humans, sand fly bite. Factors like population variability, climate change etc. lead the expansion this This article provides review epidemiology and management leishmaniasis i.e., cutaneous, mucosal, visceral. Literature was studied systematic exploration ...

Introduction: leishmaniasis is a disease caused by protozoa of the genus Leishmania and considered endemic in 98 countries. Treatment with pentavalent antimonials has high toxicity, which motivates search for effective less toxic drugs. α- β-lapachones have shown different biological activities, including antiprotozoa. In recent studies, isonicotinoylhydrazone phthalazinylhydrazone groups were ...

BACKGROUND Antimonials are still being used for visceral leishmaniasis (VL) treatment among HIV co-infected patients in East-Africa due to the shortage of alternative safer drugs like liposomal amphotericin B. Besides tolerability, emergence of resistance to antimonials is a major concern. OBJECTIVES This study was aimed at assessing the clinical outcome of VL-HIV co-infected patients when tr...